Endocrine System Drugs Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Endocrine system drugs market is anticipated to grow at a significant CAGR during the forecast period. Endocrine drugs are agents directed to a malfunctioning endocrine path. Several agents are secreted in or target the nervous system and are thus more prone to cause neurologic adverse events (AEs). The major factor for the growth of the global endocrine system drugs market is the increasing prevalence of the endocrine disease.
Furthermore, these diseases include endocrine glands
associated disorders such as Addison’s disease, gigantism, goitre, Cushing’s
syndrome, polycystic ovary syndrome (PCOS), diabetes, hypertension,
hyperlipidemia, acromegaly, thyroiditis, and osteomalacia. Additionally, the
market is also growing due to the increasing number of the adolescent populace
as they are more prone to these diseases due to hormonal imbalances.
Some major players in the market include Novo Nordisk A/S,
Eli Lilly and Company, and Novartis International AG, among others. The market
players are contributing significantly to the growth of the market by the
adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product launches,
to stay competitive in the market. For instance, in March 2020, Novartis
received the approval of Istrusia (osilodrostat) by the US FDA. It is oral
tablets used for the treatment of adult Cushing’s disease patients who cannot
undergo pituitary gland surgery or who have had the surgery, however, still
have the disease.
To Request a Sample of our Report on Endocrine System
Drugs Market: https://www.omrglobal.com/request-sample/endocrine-system-drugs-market
Market Coverage
• The market number available for – 2021-2029
• Base year- 2021
• Forecast period- 2023-2029
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Novo Nordisk A/S, Eli Lilly and Company, and Novartis International AG, among
others.
Endocrine System Drugs Market Report by Segment
By Type
• Diabetes Drug
• Human Growth Hormones
• Thyroid Hormone Disorder Drugs
• Others
By Application
• Hospitals
• Clinics
• Medical Center
• Other
A
full Report of Endocrine System Drugs Market is Available @ https://www.omrglobal.com/industry-reports/endocrine-system-drugs-market
Endocrine System
Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment